Cholinergic agonists inhibit proliferation of human fibroblast-like synoviocytes and monocytic cell lines and reduce VEGF and MMPs expression by these cells

2020 ◽  
Vol 42 (3) ◽  
pp. 246-254
Author(s):  
Delnia Arshadi ◽  
Yadollah Shakiba ◽  
Arezoo Rajabian ◽  
Behrouz Nikbin ◽  
Seyed Hadi Mousavi ◽  
...  
BioFactors ◽  
2007 ◽  
Vol 31 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Constance Schmelzer ◽  
Gerti Lorenz ◽  
Inka Lindner ◽  
Gerald Rimbach ◽  
Petra Niklowitz ◽  
...  
Keyword(s):  

2009 ◽  
Vol 7 (1) ◽  
pp. 9-17 ◽  
Author(s):  
S. Sodin-Semrl ◽  
G. Antico ◽  
R. Mikus ◽  
K. Lakota ◽  
J. Varga ◽  
...  

2009 ◽  
Vol 25 (5) ◽  
pp. e6-e7
Author(s):  
A. Iliescu ◽  
I. Gheorghiu ◽  
A.L.-A. Iliescu ◽  
R. Iliescu ◽  
B. Dimitriu ◽  
...  

2018 ◽  
Vol 99 (4) ◽  
pp. 525-535 ◽  
Author(s):  
Apamas Sukkaew ◽  
Montri Thanagith ◽  
Tipparat Thongsakulprasert ◽  
Margit Mutso ◽  
Suresh Mahalingam ◽  
...  

2012 ◽  
Vol 7 (5) ◽  
pp. 209-214 ◽  
Author(s):  
Fatemeh Hajighasem ◽  
Neda Kakadezful
Keyword(s):  

Blood ◽  
1993 ◽  
Vol 82 (9) ◽  
pp. 2649-2663 ◽  
Author(s):  
SM Watt ◽  
J Williamson ◽  
H Genevier ◽  
J Fawcett ◽  
DL Simmons ◽  
...  

The platelet-endothelial cell adhesion molecule-1 (PE-CAM-1), defined by the CD31 monoclonal antibody (MoAb), was initially described as a cell-cell adhesion molecule mediating both homotypic and heterotypic adhesion. In this report, we show that enriched CD34+ human hematopoietic progenitor cell populations, containing early myeloid, erythroid, and multipotential progenitor cells, are CD31+. Analyses of CD34+ cell lines representing early myeloid, multipotential, and pre- pre-B-lymphoid progenitors indicate that precursors of both myeloid and B-lymphoid cells express PECAM-1 at high levels. Three-color flow- cytometric analyses also show that normal human bone marrow CD31+ CD34+ subsets coexpress myeloid (CD33) or B-lymphoid (CD19, CD10) markers. Except for the monocytic cell line, U937, all CD34- cell lines tested, which represent more mature stages of the myeloid, erythroid, and lymphoid lineages, expressed substantially lower or negligible levels of PECAM-1. Western blotting studies indicated that the CD31 MoAb, JC/70A, detected molecules in the 120- to 140-kD molecular weight range on the monocytic CD34- CD33+ CD31+ cell line, U937; on the CD34+ CD31+ CD33+ CD19- multipotential/lymphomyeloid precursor cell lines, KG1 and KG1B; on the CD34+ CD31+ CD19+ CD10+ CD33- precursor pre-pre-B-cell line, MIK-ALL; and on a CD34(+)-enriched precursor cell population from normal human bone marrow. A single molecular weight species was generally observed with enriched membrane preparations, whereas two PECAM-1 molecules were present in whole-cell lysates of cell lines and the CD34+ bone marrow cell subset. Preliminary studies show that a proportion of the PECAM-1 molecules on the lymphomyeloid/multipotential progenitor cell line, KG1, and on the monocytic cell line, U937, binds to heparin-sepharose. A soluble form of PECAM-1 also binds heparin- sepharose. The high level of expression of PECAM-1 on CD34+ cells suggests that this glycoprotein may function as a heterotypic adhesion molecule, possibly mediating multipotential, myeloid, and early-B- lymphoid precursor cell interactions with stromal cells and extracellular matrix molecules via heparan sulfate proteoglycans. It may also act as a homotypic adhesion molecule by interacting with PECAM- 1 on bone marrow stromal macrophage-like cells and endothelial cells or on endothelial cells during stem/progenitor cell migration. Thus, this molecule has the potential importance of directing both lineage commitment and trafficking of early hematopoietic progenitor cells.


2018 ◽  
Vol 192 (2) ◽  
pp. 193-205 ◽  
Author(s):  
Y. Zhang ◽  
S. Wang ◽  
H. Dong ◽  
X. Yi ◽  
J. Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document